NDC 54868-2157-4 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-2157
- Requested NDC
- 54868-2157-4
- Package NDCs from labels
- 54868-2157-1, 54868-2157-2, 54868-2157-3, 54868-2157-5, 54868-2157-4
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2013-03-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OXYBUTYNIN CHLORIDE Tablets USP | Physicians Total Care, Inc. | 2013-03-18 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-2157-1 | Oxybutynin Chloride | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 54868-2157-2 | Oxybutynin Chloride | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 54868-2157-3 | Oxybutynin Chloride | 60 in 1 BOTTLE | TABLET | 60 | 4 | |
| 54868-2157-5 | Oxybutynin Chloride | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-2157 | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | 4 package rows | 20130319_19fba9db-69ff-4136-ad6b-04a33b6b6789.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-2157-1 | EA - Each | 54868-2157 | 02e0df2a-0dfd-439c-8c2b-61e8905739dc | 1 | 2012-07-24 |
| 54868-2157-2 | EA - Each | 54868-2157 | 0cab6182-6d98-4bb1-bbeb-384c0c0f42fa | 1 | 2012-07-24 |
| 54868-2157-3 | EA - Each | 54868-2157 | d5c96fe3-d79c-4f47-ab7b-ffe7bca50b54 | 1 | 2012-07-24 |
| 54868-2157-4 | EA - Each | 54868-2157 | 7b0498cd-33dd-4e1e-a7fe-0182b79207c4 | 1 | 2012-07-24 |
| 54868-2157-5 | EA - Each | 54868-2157 | f88749e7-738e-4474-9bd8-58edb87ae4d9 | 1 | 2015-02-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OXYBUTYNIN CHLORIDE | ACTIVE INGREDIENT | L9F3D9RENQ | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| OXYBUTYNIN | ACTIVE MOIETY | K9P6MC7092 | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| CALCIUM STEARATE | INACTIVE INGREDIENT | 776XM7047L | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | OXYBUTYNIN CHLORIDE TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 3f7da2a3-ca46-d3e8-e063-6294a90abef3 | 2025-12-24 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Chartwell RX, LLC | e464c8dd-5222-4a6b-b7e9-ca608a403c6e | 2025-12-22 | Warnings, Adverse reactions | L9F3D9RENQ |
| OP-P | EMOTIONAL HEALTH BOOSTER | Vitality Works, Inc. | a8b87a49-fc73-4494-8dc9-059bc5f82d42 | 2025-12-17 | Warnings | LMI26O6933 |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Accord Healthcare, Inc. | 61496a1e-17bf-4f45-a20c-5bb98fe545ee | 2025-12-16 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | AvKARE | 94471401-a516-0fe7-ec9c-447dd2bee972 | 2025-12-16 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Upsher-Smith Laboratories, LLC | 3ee6835a-7a7d-49a9-8460-2f1dd270ead3 | 2025-12-11 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Ajanta Pharma USA Inc. | 95c2a144-ba0d-4011-ae0f-0e0ca876e8a8 | 2025-11-30 | Warnings, Adverse reactions | L9F3D9RENQ |
| CONSTIPATION | MAGNESIA CARBONICA, MAGNESIA MURIATICA, AESCULUS HIPPOCASTANUM, ALUMEN, ALUMINA, BRYONIA ALBA, NUX VOMICA, SILICEA | Natural Creations, Inc. | d2e24f5a-747b-4d62-bbdf-16c0e43becdb | 2025-11-21 | Warnings | LMI26O6933 |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 44990ed6-b8e7-40f5-b636-e848024ec6d8 | 2025-11-18 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 0697b3cf-b146-47c0-b5a5-5905ae8d1c97 | 2025-11-18 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Berberis Viscum | BERBERIS VISCUM | Uriel Pharmacy Inc. | 30abbbd6-1657-4959-9f07-85ddf45f1119 | 2025-11-14 | Warnings | LMI26O6933 |
| ALUMIZEN | GARLIC, AVENA SATIVA FLOWERING TOP, BERBERIS VULGARIS ROOT BARK, ARCTIUM LAPPA ROOT, PHYTOLACCA AMERICANA ROOT, SOLIDAGO VIRGAUREA FLOWERING TOP, ALUMINUM OXIDE, SILVER NITRATE, BARIUM CARBONATE, BERYLLIUM, CADMIUM, COPPER, HYDROFLUORIC ACID, INDIUM, IODINE, LITHIUM CARBONATE, MERCURIUS SOLUBILIS, NICKEL CARBONATE HYDROXIDE TETRAHYDRATE, NITROUS OXIDE, LEAD, SELENIUM, STRONTIUM CARBONATE, TITANIUM, ARSENIC TRIOXIDE, SODIUM CHLORIDE, STRYCHNOS NUX-VOMICA SEED. | Natural Creations, Inc. | 4760ab09-1141-4944-b840-804ae6d86d2d | 2025-11-13 | Warnings | LMI26O6933 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | VERITYRX, LLC | 427b6ffb-3ff4-932f-e063-6394a90ae8b9 | 2025-10-31 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | b5653b7e-1e3b-4da3-b3a2-33318f448c67 | 2025-10-20 | Warnings, Adverse reactions | L9F3D9RENQ |
| Colostat | RHAMNUS PURSHIANA, SPIGELIA ANTHELMIA, TARAXACUM OFFICINALE, CAJUPUTUM, HYDRASTIS CANADENSIS, ALUMINA, CINA, CINCHONA OFFICINALIS, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, MANDRAGORA OFFICINARUM, NUX VOMICA | Energique, Inc. | 89c86e7b-304c-43a6-81e7-373d95c9fac1 | 2025-10-06 | Warnings | LMI26O6933 |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2025-10-02 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Major Pharmaceuticals | 7769ad3d-6228-4b2d-8f44-4efe990d3fad | 2025-09-19 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Jet Lag | ECHINACEA, ALUMINA, ARALIA QUINQUEFOLIA, ARGENTUM, ARNICA MONTANA, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BRYONIA, CANTHARIS, CHELIDONIUM MAJUS, CONIUM MACULATUM, GELSEMIUM SEMPERVIRENS, IODIUM, KALI CARBONICUM, KALI IODATUM, LYCOPODIUM CLAVATUM, LYCOPUS VIRGINICUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, PHYTOLACCA DECANDRA, PULSATILLA, RHUS TOXICODENDRON, SABAL SERRULATA, THYROIDINUM. | Newton Laboratories, Inc. | 9c21c935-4ebc-1efd-e053-2995a90aa156 | 2025-09-18 | Warnings | LMI26O6933 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Cardinal Health 107, LLC | 8455b543-81ce-4522-ae9b-8396f944945c | 2025-08-18 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2025-08-18 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.